NSERC/MDS Analytical Technologies Industrial Research Chair in Analytical Mass Spectrometry

这项提议是为了续任NSERC/MDS分析技术工业研究教席的第三个任期。该IRC与工业合作伙伴MDS分析技术公司(AT，前身为SCIEX)合作，研究开发新的质谱学硬件(MS)和应用程序。这份更新建议包括正在进行的合作项目和与MDS AT共同开发的新项目。与目前的做法一样，许多这样的项目将在约克大学的教席实验室和MDS AT的合作者实验室进行。SiU的研究生、博士后研究员和MDS AT工作人员将能够在两个合作机构之间的短暂物理分隔(开车15分钟)促进下在两个地点进行研究。主席的研究计划的很大一部分将致力于了解和开发新的离子解离方法和仪器。其中包括由主席的团队首次在四极/飞行时间(QqTOF)混合质谱仪(QqTOF)质谱仪(QSTAR MDS的原型)中实施的红外多光子解离；以及紫外线解离，这是一个新项目，其初步数据显示出相当大的前景。这项研究的结果将有助于更好地了解这些解离方法在MDS AT制造的QqTOF和其他类型的MS/MS仪器上实施的潜力，并可能导致商业产品。同样重要的是致力于更好地对多肽和小分子药物进行定量分析的项目。这些项目包括调查多重反应监测，使用差动迁移率分析仪和增强的多重电荷扫描，以提高快速分离的选择性，以及从加强量化的角度简化离子分布的离子停放。此外，将致力于在第二届主席任期内开发的一种新仪器中应用离子迁移率光谱，该仪器集成了离子迁移率和三重四极杆MS，用于药物代谢物表征，补充了MS。

This proposal is for renewal of a third term of the NSERC / MDS Analytical Technologies Industrial Research Chair in Analytical Mass Spectrometry. This IRC conducts research in developing novel hardware in mass spectrometry (MS) and applications in collaboration with MDS Analytical Technologies (AT, formerly SCIEX), the Industrial Partner. This proposal for renewal comprises ongoing collaborative projects and new projects developed with MDS AT. As in current practice, many of these projects will be carried out in both the Chair's laboratories in York University and his collaborators' laboratories in MDS AT. Siu's graduate students, postdoctoral fellows, and MDS AT staff will be able to conduct research in both locations, facilitated by the short physical separation (-15 minutes by car) between the two collaborating institutions. A significant portion of the Chair's research program will be devoted to understanding and developing of new ion dissociation methods and instrumentation. These include infrared multiphoton dissociation, implemented for the first time in a hybrid quadrupole / time-of-flight (QqTOF) mass spectrometer (a prototype of the MDS AT QSTAR) by the Chair's team; and ultraviolet dissociation, a new project whose preliminary data show considerable promise. Results of this research will lead to a better understanding of the potential of these dissociation methods for implementation on the QqTOF and other types of MS/MS instrumentation that are manufactured by MDS AT, and may lead to commercial products. Equally significant are projects devoted to better quantitative analyses of peptide and small-molecule drugs. These projects include investigations into multiple-reaction monitoring, the use of a differential mobility analyzer and the enhanced multiply charge scan for improved selectivity in fast separations, and ion parking for simplifying ion distributions from the perspective of enhancing quantification. In addition, efforts will be devoted to apply ion mobility spectrometry in a novel instrumentation developed during the second Chair term that integrates ion mobility and triple quadrupole MS for drug metabolite characterization that complements MS.